In addition, FDA is proposing two other constraints around the submission of the supplemental PMTA. Beneath proposed §?1114.15(a), a supplemental PMTA couldn't be submitted exactly where the advertising and marketing order for the initial tobacco products is withdrawn or continues to be quickly suspended or is the topic of non permanent suspension